Greenebaum Cancer Center at University of Maryland Medical Center

Baltimore, Maryland 21201

We've found

3 trials

at this facility

Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer

Status: Enrolling, Phase II
Updated: 12/6/2012

from

Baltimore, MD

Pentamidine in Treating Patients With Relapsed or Refractory Melanoma

Status: Enrolling, Phase II
Updated: 12/16/2009

from

Baltimore, MD

1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell Transplantation

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Baltimore, MD

Use our guide to learn which trials are right for you!